DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 076260
NDA 076260 describes BRIMONIDINE TARTRATE, which is a drug marketed by Akorn, Bausch And Lomb, Indoco Remedies, Sandoz Inc, and Teva Parenteral, and is included in six NDAs. It is available from six suppliers. Additional details are available on the BRIMONIDINE TARTRATE profile page.
The generic ingredient in BRIMONIDINE TARTRATE is brimonidine tartrate. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the brimonidine tartrate profile page.
The generic ingredient in BRIMONIDINE TARTRATE is brimonidine tartrate. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the brimonidine tartrate profile page.
Summary for 076260
| Tradename: | BRIMONIDINE TARTRATE |
| Applicant: | Bausch And Lomb |
| Ingredient: | brimonidine tartrate |
| Patents: | 0 |
| Therapeutic Class: | Ophthalmic Agents |
Pharmacology for NDA: 076260
| Mechanism of Action | Adrenergic alpha-Agonists |
Medical Subject Heading (MeSH) Categories for 076260
Suppliers and Packaging for NDA: 076260
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BRIMONIDINE TARTRATE | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 076260 | ANDA | Bausch & Lomb Incorporated | 24208-411 | N | 24208-411-10 |
| BRIMONIDINE TARTRATE | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 076260 | ANDA | Bausch & Lomb Incorporated | 24208-411 | N | 24208-411-15 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.2% | ||||
| Approval Date: | May 28, 2003 | TE: | AT | RLD: | No | ||||
Complete Access Available with Subscription
